Cara Therapeutics(CARA) - 2024 Q1 - Quarterly Results
Cara Therapeutics(US:CARA)2024-05-13 20:10– Topline ef icacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP) pivotal program now expected by the end of 2Q24 – In March 2024, the Company hosted a virtual event, Meet the NP Experts, featuring a panel of leading dermatologists and key opinion leaders to discuss the unmet need in NP and the potential of oral difelikefalin. A replay of the webcast is available under "Events & Presentations" in the Investors section of the Company's website, www.CaraTherapeutics.com. First ...